Cabo Verde vs Côte d'Ivoire: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cabo Verde
0.7%
in 2024
Côte d'Ivoire
0.6%
in 2024
Cabo Verde rank
51st
Côte d'Ivoire rank
60th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cabo Verde
- Côte d'Ivoire
How they compare
Cabo Verde currently reports 0.7% against 0.6% in Côte d'Ivoire, a difference of 0.1%.
That makes Cabo Verde's figure about 1.2 times Côte d'Ivoire's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Côte d'Ivoire ahead.
Cabo Verde ranks 51st and Côte d'Ivoire ranks 60th of 246 countries.
Côte d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cabo Verde | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 1.2% | 0.4% | Côte d'Ivoire |
| 2020s | 0.6% | 0.7% | 0.1% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cabo Verde or Côte d'Ivoire?
- Cabo Verde, at 0.7% against 0.6% in Côte d'Ivoire as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cabo Verde and Côte d'Ivoire?
- 0.1%, with Cabo Verde ahead.
- How many years of comparable data are there for Cabo Verde and Côte d'Ivoire?
- 10 years are reported by both, from 2015 to 2024.
- How do Cabo Verde and Côte d'Ivoire rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cabo Verde ranks 51st and Côte d'Ivoire ranks 60th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.